{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:18:08Z","timestamp":1790543888195,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T00:00:00Z","timestamp":1565740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013153","name":"Shantou Science and Technology Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013153","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Orthopaedic Translation"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jot.2019.08.004","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T16:36:24Z","timestamp":1568046984000},"page":"7-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["The efficacy and safety of denosumab in postmenopausal women with osteoporosis previously treated with bisphosphonates: A review"],"prefix":"10.1016","volume":"22","author":[{"given":"Yilin","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonglian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weicai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiankun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuantao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jot.2019.08.004_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/CIA.S15711","article-title":"Efficacy and safety of bazedoxifene for postmenopausal osteoporosis","volume":"6","author":"Kawate","year":"2011","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.jot.2019.08.004_bib2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/jwh.2013.4611","article-title":"Osteoporosis prevention, screening, and treatment: a review","volume":"23","author":"Kling","year":"2014","journal-title":"J\u00a0Women's Health"},{"key":"10.1016\/j.jot.2019.08.004_bib3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.maturitas.2013.05.013","article-title":"Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013","volume":"75","author":"Compston","year":"2013","journal-title":"Maturitas"},{"key":"10.1016\/j.jot.2019.08.004_bib4","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/S0140-6736(06)68891-0","volume":"367","author":"Sambrook","year":"2006","journal-title":"Osteoporos Lancet"},{"key":"10.1016\/j.jot.2019.08.004_bib5","first-page":"728","article-title":"Comparing adherence and persistence across 6 chronic medication classes","volume":"15","author":"Yeaw","year":"2009","journal-title":"J\u00a0Manag Care Pharm"},{"key":"10.1016\/j.jot.2019.08.004_bib6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11926-008-0021-x","article-title":"Compliance and persistence with osteoporosis therapies","volume":"10","author":"Silverman","year":"2008","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jot.2019.08.004_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00198-009-0930-1","article-title":"Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis","volume":"21","author":"Cotte","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jot.2019.08.004_bib8","doi-asserted-by":"crossref","first-page":"856","DOI":"10.4065\/80.7.856","article-title":"Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women","volume":"80","author":"Recker","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jot.2019.08.004_bib9","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00198-006-0322-8","article-title":"A\u00a0systematic review of persistence and compliance with bisphosphonates for osteoporosis","volume":"18","author":"Cramer","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jot.2019.08.004_bib10","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1002\/jbmr.119","article-title":"Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomised, multicenter, double-blind, active-controlled study","volume":"25","author":"Orwoll","year":"2010","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jot.2019.08.004_bib11","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bone.2007.03.011","article-title":"Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate","volume":"41","author":"McClung","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.jot.2019.08.004_bib12","first-page":"7","article-title":"Atypical femoral fractures and current managements","volume":"7","author":"Zheng","year":"2016","journal-title":"J\u00a0Orthop Transl"},{"key":"10.1016\/j.jot.2019.08.004_bib13","first-page":"1","article-title":"Hybrid fracture fixation systems developed for orthopaedic applications, a general review","volume":"16","author":"Tian","year":"2018","journal-title":"J\u00a0Orthop Transl"},{"key":"10.1016\/j.jot.2019.08.004_bib14","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJMc1403799","article-title":"Risk of atypical femoral fracture during and after bisphosphonate use","volume":"10","author":"Schilcher","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jot.2019.08.004_bib15","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMc1107029","article-title":"Atypical femoral fractures and bone tumover","volume":"13","author":"Jamal","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jot.2019.08.004_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/gme.0b013e3181c617e6","article-title":"Management of osteoporosis in postmenopansal women: 2010 position statement of the North American Menopause Society","volume":"17","author":"Bonnick","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.jot.2019.08.004_bib17","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1530\/EJE-11-0454","article-title":"Denosumab for bone diseases: translating bone biology into targeted therapy","volume":"165","author":"Tsourdi","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jot.2019.08.004_bib18","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1359\/jbmr.070809","article-title":"Two-year treatment with denosumab (AMG 162) in a randomised phase 2 study of postmenopausal women with low BMD","volume":"22","author":"Lewiecki","year":"2007","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jot.2019.08.004_bib19","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bone.2008.04.007","article-title":"Effect\u00a0of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting\u00a0of therapy: a randomised blinded phase 2 clinical trial","volume":"43","author":"Miller","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.jot.2019.08.004_bib20","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1210\/jc.2010-1502","article-title":"Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass","volume":"96","author":"Bone","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jot.2019.08.004_bib21","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","article-title":"Denosumab in postmenopausal women with low bone mineral density","volume":"354","author":"McClung","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jot.2019.08.004_bib22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2147\/CIA.S14565","article-title":"Clinical utility of denosumab for treatment of bone loss in men and women","volume":"6","author":"Adler","year":"2011","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.jot.2019.08.004_bib23","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","first-page":"190","article-title":"Chapter 8: assessing rick of bias in included studies","author":"Higgins","year":"2008"},{"key":"10.1016\/j.jot.2019.08.004_bib24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1359\/jbmr.090716","article-title":"Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy","volume":"25","author":"Kendler","year":"2010","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jot.2019.08.004_bib25","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/AOG.0b013e318291718c","article-title":"Denosumab compared with ibandronate in postmenopausal women previously treated with bisphosphonate therapy: a randomised open-label trial","volume":"121","author":"Recknor","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jot.2019.08.004_bib26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bone.2013.10.006","article-title":"Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: efficacy and safety results from a randomised open-label study","volume":"58","author":"Roux","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.jot.2019.08.004_bib27","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1210\/jc.2016-1801","article-title":"Denosumab or zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonates","volume":"101","author":"Miller","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jot.2019.08.004_bib28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-011-1620-3","article-title":"Treatment satisfaction and persistence among postmenopausal women on osteoporosis medications: 12-month results from POSSIBLE US","volume":"23","author":"Barrett-Connor","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jot.2019.08.004_bib29","first-page":"1285","article-title":"Effect of oral clonidine on acute intraocular pressure rise after cataract extraction under general anaesthesia","volume":"62","author":"Boroojeny","year":"2012","journal-title":"J\u00a0Pak Med Assoc"},{"key":"10.1016\/j.jot.2019.08.004_bib30","first-page":"1007","article-title":"Denosumab: a review of its use in postmenopausal woman with osteoporosis","volume":"23","author":"Sun","year":"2015","journal-title":"Orthop J China,"},{"key":"10.1016\/j.jot.2019.08.004_bib31","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/ncpendmet0838","article-title":"How does teriparatide compare with alendronate for the treatment of glucocorticoid-induced osteoporosis?","volume":"4","author":"Rizzoli","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"}],"container-title":["Journal of Orthopaedic Translation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214031X19302001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214031X19302001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:40:23Z","timestamp":1761993623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214031X19302001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":31,"alternative-id":["S2214031X19302001"],"URL":"https:\/\/doi.org\/10.1016\/j.jot.2019.08.004","relation":{},"ISSN":["2214-031X"],"issn-type":[{"value":"2214-031X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy and safety of denosumab in postmenopausal women with osteoporosis previously treated with bisphosphonates: A review","name":"articletitle","label":"Article Title"},{"value":"Journal of Orthopaedic Translation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jot.2019.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier (Singapore) Pte Ltd on behalf of Chinese Speaking Orthopaedic Society.","name":"copyright","label":"Copyright"}]}}